Unknown authors · 2026
Researchers developed a new magnetic device that uses spinning oscillating magnetic fields to selectively kill aggressive brain cancer cells while leaving healthy brain cells unharmed. The device works by damaging the energy-producing parts of cancer cells, causing them to die through a natural cell death process. This represents a potentially safer approach to treating deadly brain cancers like glioblastoma.
Unknown authors · 2026
Korean researchers exposed male rats to CDMA-modulated 900 MHz radiofrequency radiation at 4 W/kg (the international safety guideline level) for nearly their entire lifespans. They found no increased cancer rates, no genetic damage, and no effects on heart, brain, or adrenal glands. This was part of a coordinated study with Japan to verify earlier National Toxicology Program findings.
Unknown authors · 2026
Japanese researchers exposed rats to 900 MHz cell phone radiation at high levels (4 W/kg) for nearly two years to test cancer risk. They found no increase in tumors or DNA damage, contradicting earlier U.S. studies that suggested RF radiation might cause brain and heart tumors in rats.
Rather than suggesting that there are ‘no consistent effects et al. · 2025
This 2025 review examines how radiofrequency electromagnetic fields can be used therapeutically in cancer treatment. The authors argue that cancer cells have different electrical properties than normal cells, making them potentially vulnerable to specific RF-EMF treatments that have shown promise in clinical trials with minimal side effects.
Tahmasebi et al · 2025
Iranian researchers studied 226 women to examine whether mobile phone use increases breast cancer risk. They found women who talked on phones for more than 60 minutes daily had 3.5 times higher odds of confirmed breast cancer compared to those using phones less than 10 minutes daily. The study also included a 'suspected' group of women advised to get mammograms, who showed even higher associations with phone use.
Mevissen et al · 2025
This comprehensive 2025 review analyzed 52 animal studies to evaluate whether radiofrequency electromagnetic field exposure causes cancer. Researchers found high-certainty evidence for increased brain tumors (gliomas) and heart tumors (schwannomas) in male rats, the same tumor types previously linked to cell phone use in humans. The findings strengthen concerns about RF-EMF carcinogenicity that led to its classification as a possible human carcinogen in 2011.
Unknown authors · 2025
Researchers conducted the largest genetic study of nasopharyngeal carcinoma (NPC), analyzing nearly 14,000 people to identify genetic variants that increase cancer risk. They found three key genetic changes that make people more susceptible to this throat cancer, with one variant affecting how Epstein-Barr virus (EBV) behaves in cells. The study reveals how genetics and viral infections work together to cause this cancer.
Unknown authors · 2025
Researchers exposed bladder cancer cells (HT-1197) to pulsed electromagnetic field (PEMF) therapy for one hour daily over five days. The treated cancer cells grew significantly slower than untreated cells and showed major changes in gene expression patterns. This suggests PEMF therapy might offer a less invasive treatment approach for bladder cancer patients.
Unknown authors · 2025
Researchers exposed prostate cancer cells to extremely low-frequency pulsed electromagnetic fields at 22.6 and 35 mT intensities. The treatment killed cancer cells and activated genes that suppress tumors while reducing genes that promote cancer growth. This suggests EMF therapy could potentially help treat prostate cancer with fewer side effects than traditional treatments.
Moon et al · 2024
Korean researchers analyzed 24 studies involving cell phone use and brain tumors, finding that people who used phones on the same side of their head where tumors developed had 40% higher odds of brain cancer. The risk increased with longer use, reaching 59% higher odds for those with over 896 hours of cumulative phone time.
Unknown authors · 2024
Researchers exposed breast cancer cells to extremely low-frequency electromagnetic fields (1 Hz, 100mT) for 2 hours daily over 5 days. The EMF exposure significantly reduced cancer cell invasion and migration while increasing protective E-cadherin proteins and decreasing harmful N-cadherin proteins. This suggests ELF-EMF might potentially help prevent breast cancer metastasis.
Unknown authors · 2024
Italian researchers exposed Schwann cells (nerve-supporting cells) to electromagnetic fields at 50 Hz frequency for 10 minutes and found the cells shifted toward a less healthy state. The study suggests EMF exposure may trigger epigenetic changes that could contribute to schwannoma tumor development. This adds laboratory evidence to epidemiological studies linking EMF exposure to peripheral nerve tumors.
Unknown authors · 2024
Researchers tested whether combining silver nanoparticles with extremely low frequency electromagnetic fields (50 mT for 30 minutes) could better kill laryngeal cancer cells. The combination was 6 times more effective at destroying cancer cells than nanoparticles alone, triggering cell death and blocking cancer cell reproduction. This suggests EMF might enhance certain cancer treatments under controlled conditions.
Unknown authors · 2024
Researchers combined silver nanoparticles with extremely low frequency electromagnetic fields (50 mT for 30 minutes) to attack human laryngeal cancer cells. The combination increased cancer cell death by 6-fold compared to nanoparticles alone. This suggests EMF can enhance certain medical treatments, though the high field strength used far exceeds typical environmental exposure.
Unknown authors · 2023
Researchers exposed breast cancer cells to power line frequency magnetic fields (50 Hz at 1 milliTesla for 4 hours) and found the fields made cancer cells more aggressive. The exposed cancer cells grew faster, developed more invasive structures, and showed increased ability to migrate and invade surrounding tissue.
Unknown authors · 2023
Researchers developed gold-based nanoparticles that use near-infrared light to trigger a specific type of cell death called ferroptosis in brain cancer cells. The study found these particles could cross the blood-brain barrier and selectively target glioblastoma tumors while extending survival time in mice. This represents a new approach to treating aggressive brain cancers using light-activated therapy.
Unknown authors · 2023
Italian researchers studied 182 children with leukemia and 726 healthy controls to see if living near electrical transformer stations increases cancer risk. They found no overall increased risk, but children aged 5 and older showed some elevated risk when living within 15-25 meters of transformers. The study was limited by small numbers of children actually living that close to transformer stations.
Unknown authors · 2023
Scientists analyzed genetic data from over 172,000 people of East Asian ancestry to identify genetic variants that increase lung cancer risk. They discovered 12 new genetic markers linked to lung adenocarcinoma, with most findings specific to East Asian populations rather than Europeans. The genetic risk factors were stronger in people who never smoked compared to smokers.
Unknown authors · 2023
This clinical trial studied 421 kidney cancer patients comparing a combination immunotherapy treatment (toripalimab plus axitinib) against standard chemotherapy (sunitinib). The combination therapy significantly extended progression-free survival from 9.8 months to 18.0 months and doubled response rates from 31% to 57%.
Unknown authors · 2023
Researchers analyzed genetic data from over 172,000 people of East Asian ancestry to identify genetic variants that increase lung cancer risk. They discovered 12 new genetic markers linked to lung adenocarcinoma, the most common type of lung cancer. Importantly, these genetic risk factors had stronger effects in people who never smoked compared to smokers.
Unknown authors · 2023
Researchers developed gold-based nanoparticles that use near-infrared light to trigger a specific type of cell death called ferroptosis in brain tumor cells. The nanoparticles can cross the blood-brain barrier and be tracked visually, allowing doctors to see exactly where they go in the brain. This approach successfully extended survival time in mice with brain tumors by specifically targeting cancer cells while sparing healthy tissue.
Unknown authors · 2023
Researchers developed gold-based nanoparticles that use near-infrared light to trigger a specific type of cell death called ferroptosis in brain tumors. The nanoparticles successfully crossed the blood-brain barrier and selectively killed glioblastoma cells while extending survival time in mice. This represents a new approach using gold instead of iron to activate targeted cancer cell death.
Unknown authors · 2022
This comprehensive review examined how cancer cells reshape the extracellular matrix (the structural framework surrounding cells) to promote tumor growth and evade immune system attacks. Researchers found that tumors actively remodel this cellular scaffolding to create a protective barrier that helps cancer spread and resist treatment. The findings suggest that 'normalizing' this altered matrix could offer new therapeutic approaches.
Unknown authors · 2022
Researchers tested extremely low frequency electromagnetic fields (ELF-EMF) and silver nanoparticles against bacteria and breast cancer cells. The combination achieved 100% bacterial kill rates and triggered cancer cell death through programmed cell destruction. The study suggests these agents work by creating oxidative stress that damages harmful cells while potentially sparing healthy ones.
Unknown authors · 2022
Researchers exposed normal and gastric cancer cells to extremely low frequency magnetic fields at different intensities for 18 hours. They found that specific field strengths (0.25 and 0.5 millitesla) reduced cancer cell viability while boosting normal cell health, and decreased expression of genes linked to tumor growth and spread. This suggests certain EMF exposures might have therapeutic potential against gastric cancer.